How much funding has ANPLAT raised?

ANPLAT has raised $360K in total funding, most recently a Seed round.

Who are ANPLAT's investors?

ANPLAT's investors include ANRI, DeepCore.

Where is ANPLAT headquartered?

ANPLAT is headquartered in Yokohama, Japan.

What industry is ANPLAT in?

ANPLAT operates in Biotech, SaaS.

ANPLAT

株式会社アンプラット – あらゆる解析技術を研究者の共有財産に

Yokohama, Japan · $360K raised

Biotech

SaaS

Headquarters: Yokohama
Employees: 1–10
Business Model: B2B
Website: anplat.co.jp

Total Funding: $360K
Last Round: $360K SeedApr 2021
Rounds: 1

About

ANPLAT (株式会社アンプラット) is a Japanese biotech software company that develops and operates ANCAT, a bioinformatics analysis platform designed to make advanced genomics and data analysis methods accessible to researchers without deep IT expertise. ANCAT allows scientists to browse, search, and execute diverse bioinformatics analysis pipelines through an intuitive GUI, and to share those methods with the broader research community as a public catalog. The company also provides Lab DX consulting services to help research institutions digitalize their operations and build cloud-based analytical environments.

Summary

ANPLAT is a Biotech company based in Yokohama, Japan. It has raised $360K in total across 1 round, most recently a $360K Seed round in Apr 2021. Investors include ANRI and DeepCore.